1-7 of 7
Jonathan Rosenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)

Free
Jonathan Rosenberg, Renaud Sabatier, Armelle Viceneux, Thibault de La Motte Rouge, Stephane Champiat, Loic Lebellec, Philippe Barthélémy, Guru Sonpavde, Xin Gao, Scot Niglio, Tian Zhang, Craig Gedye, Matthew Galsky, Matthew Milowsky, Melissa Reimers, Andrew Weickhardt, Enrique Grande, Daniel E. Castellano, Mehmet Bilen, Amita Patnaik, Robert Zerbib, Minna Balbas, Xiaojian Xu, Kaitlyn Aptaker, Arjun V. Balar, Ahmad H. Awada
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT084.
https://doi.org/10.1158/1538-7445.AM2024-CT084
Published: 05 April 2024
View articletitled, Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)
Journal Articles

Abstract CT115: Phase 1b KEYNOTE 200 (STORM study): A study of an intravenously delivered oncolytic virus, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients

Free
Hardev Pandha, Kevin Harrington, Cristy Ralph, Alan Melcher, Sumati Gupta, Wallace Akerley, Rachael E. Sandborn, Charles Rudin, Jonathan Rosenberg, David Kaufman, Emmett Schmidt, Mark Grose, Darren R. Shafren
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT115.
https://doi.org/10.1158/1538-7445.AM2017-CT115
Published: 01 July 2017
View articletitled, Abstract CT115: Phase 1b KEYNOTE 200 (STORM study): A study of an intravenously delivered oncolytic virus, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients
Journal Articles

Abstract NG06: Genomic dissection of the clonal evolution dynamics of chemotherapy-resistant urothelial carcinoma

Free
Bishoy M. Faltas, Davide Prandi, Scott T. Tagawa, Ana M. Molina, David M. Nanus, Cora Sternberg, Jonathan Rosenberg, Juan Miguel Mosquera, Brian Robinson, Olivier Elemento, Andrea Sboner, Himisha Beltran, Francesca Demichelis, Mark A. Rubin
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): NG06.
https://doi.org/10.1158/1538-7445.AM2017-NG06
Published: 01 July 2017
View articletitled, Abstract NG06: Genomic dissection of the clonal evolution dynamics of chemotherapy-resistant urothelial carcinoma
Journal Articles

Abstract 375: Oncologist use and perception of large panel next generation tumor sequencing

Free
Alison M. Schram, Dalicia Reales, Jesse Galle, Roy Cambria, Robert Durany, Darren Feldman, Eric Sherman, Jonathan Rosenberg, Gabriella D'Andrea, Shrujal Baxi, Yelena Janjigian, William Tap, Maura Dickler, José Baselga, Barry Taylor, Debyani Chakravarty, Jianjiong Gao, Nikolaus D. Schultz, David B. Solit, Michael F. Berger, David M. Hyman
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 375.
https://doi.org/10.1158/1538-7445.AM2017-375
Published: 01 July 2017
View articletitled, Abstract 375: Oncologist use and perception of large panel next generation tumor sequencing
Journal Articles

Abstract 4149: Transcriptomic and pathogen analysis in bladder cancer primary tumor and metastasis pairs.

Free
Ami S. Bhatt, Chandra Sekhar Pedamallu, Fujiko Duke, Joonil Jung, Samuel S. Freeman, Andrew Cherniak, Rachel Park, Jaegil Kim, David Kwiatkowski, Jonathan Rosenberg, Matthew Meyerson
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4149.
https://doi.org/10.1158/1538-7445.AM2013-4149
Published: 15 April 2013
View articletitled, Abstract 4149: Transcriptomic and pathogen analysis in bladder cancer primary tumor and metastasis pairs.
Journal Articles

Abstract 4066: Loss of Sh3gl2/endophilin A1 is an early event in urothelial carcinoma that regulates malignant behavior.

Free
Shyama Majumdar, Edward Gong, Dolores Di Vizio, Jonathan Dreyfuss, David DeGraff, Martin Hager, Peter Park, Joaquim Bellmunt, Robert Matusik, Jonathan Rosenberg, Rosalyn Adam
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4066.
https://doi.org/10.1158/1538-7445.AM2013-4066
Published: 15 April 2013
View articletitled, Abstract 4066: Loss of Sh3gl2/endophilin A1 is an early event in urothelial carcinoma that regulates malignant behavior.
Journal Articles

Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

Free
Lawrence Fong, Serena S. Kwek, Shaun O'Brien, Brian Kavanagh, Douglas G. McNeel, Vivian Weinberg, Amy M. Lin, Jonathan Rosenberg, Charles J. Ryan, Brian I. Rini, Eric J. Small
Journal: Cancer Research
Cancer Res (2009) 69 (2): 609–615.
https://doi.org/10.1158/0008-5472.CAN-08-3529
Published: 15 January 2009
View articletitled, Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Open the PDF for Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF in another window